Clinical Trial

EFFECTS OF OLEUROPEIN ON BLOOD PARAMETERS AND INFLAMMATORY MARKERS IN ADULTS WITH METABOLIC SYNDROME

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 5, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to determine the effect of 6 weeks supplementation of oleuropein on individuals diagnosed with metabolic syndrome. The baseline and end biochemical parameters and anthropometric measurements will be compared with control subjects.
Trial Details
NCT Number NCT06673914
Lead Sponsor Atlas University
Conditions Metabolic Syndrome, Insulin Resistance, Obesity, Abdominal, Obesity
Enrollment 34 participants
Start Date 2024-11-01
Primary Completion 2024-12-30 (estimated)
Study Completion 2025-01-15 (estimated)
Updated on ClinicalTrials.gov 2024-11-05